Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Caterina MARCHIO'

Associate Professor of Pathology

University of Turin

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

30%

Cell Biology

50%

Cancer Biology

70%

Cancer Research

30%

Oncology

30%

Immunohistochemistry

20%

Ovarian Cancer

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

Article Link

Year:

2025

Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study

Article Link

Year:

2024

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

Article Link

Year:

2023

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

Article Link

Year:

2023

The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

Article Link

Year:

2023

Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time

Article Link

Year:

2023

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

Article Link

Year:

2022

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

Article Link

Year:

2022

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

Article Link

Year:

2022

HER2-Low Breast Cancer: Where Are We?

Article Link

Year:

2022

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives

Article Link

Year:

2022

Molecular Characterization of Prostate Cancers in the Precision Medicine Era

Article Link

Year:

2021

Collaborators27

Sharon Glynn

Associate Professor in Pathology

University of Galway

IRELAND

Valeria Leuci

Candiolo Cancer Institute

ITALY

Laura Annaratone

University of Turin

ITALY

Vurchio Valentina

Università degli Studi di Torino

ITALY

Livio Trusolino

Full Professor, University of Torino School of Medicine

Candiolo Cancer Institute, FPO-IRCCS

ITALY

ELIA BARI

Assistant professor

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY

Irene Catalano

Candiolo Cancer Institute, FPO-IRCCS

ITALY

Anikó Kovács

University of Gothenburg

SWEDEN

Francesco Sassi

Candiolo Cancer Institute, FPO-IRCCS

ITALY

Enrico Berrino

Università degli Studi di Foggia Dipartimento di Scienze Mediche e Chirurgiche

ITALY

Evandro de Azambuja

Institut Jules Bordet

BELGIUM

Peter Regitnig

Medical University of Graz

AUSTRIA

Serena Bonin

Associate Professor

University of Trieste

ITALY

Tiziana Venesio

Candiolo Cancer Institute, FPO-IRCCS

ITALY

Elena Grassi

Candiolo Cancer Institute, FPO-IRCCS

ITALY

Paolo Marchetti

Sapienza University of Rome

ITALY

sara erika bellomo

Candiolo Cancer Institute, FPO-IRCCS

ITALY

Giulia M. Stella

ITALY

paolo fattorini

Prof.

University of Trieste

ITALY

Umberto Miglio

Candiolo Cancer Institute, FPO-IRCCS

ITALY

soldano ferrone

Professor

UNITED STATES

Silvia GIORDANO

full professor

University of Turin

ITALY

Maria P. Foschini

Full Professor of Anatomic Pathology

University of Bologna

ITALY

Ilaria Ferrarotti

Assistant Professor

University of Pavia

ITALY

Dario Sangiolo

University of Turin

ITALY

Anna Sapino

Full Professor of Pathology

Università degli Studi di Torino

ITALY

GIULIA MESIANO

Candiolo Cancer Institute, FPO-IRCCS

ITALY

How do I reach out?

Meet Kite AI

Caterina MARCHIO'

Associate Professor of Pathology

How do I reach out?

Contact this professor

Research Interests

Ask ApplyKite AI

Articles12

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

Quantifying mRNA in Highly Degraded Fixed Tissues by Nanostring Technology: A Comparative Study

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer

The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints

Tissue Fixation with a Formic Acid-Deprived Formalin Better Preserves DNA Integrity over Time

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients

Definition of High-Risk Early Hormone-Positive HER2&minus;Negative Breast Cancer: A Consensus Review

HER2-Low Breast Cancer: Where Are We?

Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives

Molecular Characterization of Prostate Cancers in the Precision Medicine Era

Collaborators27

Sharon Glynn

Valeria Leuci

Laura Annaratone

Vurchio Valentina

Livio Trusolino

ELIA BARI

Irene Catalano

Anikó Kovács

Francesco Sassi

Enrico Berrino

Evandro de Azambuja

Peter Regitnig

Serena Bonin

Tiziana Venesio

Elena Grassi

Paolo Marchetti

sara erika bellomo

Giulia M. Stella

paolo fattorini

Umberto Miglio

soldano ferrone

Silvia GIORDANO

Maria P. Foschini

Ilaria Ferrarotti

Dario Sangiolo

Anna Sapino

GIULIA MESIANO

How do I reach out?

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review